Lower Retear Rates After Rotator Cuff Repair: PRP Evidence and Use

PRP injections can offer modest, often durable improvement in pain and function for many patients with rotator cuff tendinopathy or partial-thickness tears. Evidence for using PRP to routinely heal full-thickness tears without surgery remains mixed, though PRP shows clearer promise as an adjunct during arthroscopic repair. The right choice depends on your tear type, how long you’ve had symptoms, which treatments you’ve already tried, and which PRP formulation your provider uses.

TL;DR:

PRP shows modest, durable benefits in pain and function for tendinopathy and partial tears but has limited evidence as a standalone cure for large full-thickness tears.

The effectiveness of PRP heavily depends on the formulation used, with leukocyte-rich and leukocyte-poor types potentially influencing outcomes, and preparation methods vary widely.

Recent research indicates lower retear rates when PRP is applied as a surgical adjunct during arthroscopic rotator cuff repair, particularly in higher-risk, larger tears.

PRP typically results in symptom relief within 8 to 12 weeks, with full functional improvement often continuing up to six months, and safety profiles are generally favorable.

Cost and insurance coverage are inconsistent, making pre-authorization and clear understanding of the specific PRP formulation crucial before proceeding.

Nowak Orthopedic Associates

Explore Options for Shoulder Pain

Nowak Orthopedic Associates provides shoulder care, arthroscopic surgery, and PRP injections for joint injuries and related conditions.

Visit Nowak Orthopedic Associates

What PRP is and why formulation matters
How strong is the research behind PRP for rotator cuff injuries?
PRP compared with corticosteroid and hyaluronic acid injections
PRP as a surgical adjunct during rotator cuff repair
Who should consider PRP: a decision checklist
What to expect: the visit, recovery, and cost
How Nowak Orthopedic Associates applies the evidence
Where the evidence leads and what gets overstated
Scheduling a shoulder evaluation with our team
Sources
FAQ

What PRP is and why formulation matters

Platelet-rich plasma is a concentration of a patient’s own platelets, drawn from a small blood sample and spun down to separate out the components that carry healing signals. Platelets release growth factors, including platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-β), and vascular endothelial growth factor (VEGF), which are thought to support tendon cell activity and modulate local inflammation. This biologic signaling is the theoretical basis for using PRP in tendon injuries, though the exact clinical impact varies by preparation and patient.

Not all PRP is the same, and that variability explains much of the inconsistency in the research. Two broad categories dominate clinical use:

Leukocyte-rich PRP (LR-PRP) contains a higher concentration of white blood cells, which some clinicians believe amplifies inflammatory signaling in the short term.
Leukocyte-poor PRP (LP-PRP) filters out most white blood cells and is often favored for tendon applications where excess inflammation may be less desirable.

Preparation itself is simple in concept: a blood draw, centrifugation to separate plasma layers, and extraction of the platelet-concentrated layer for injection, usually completed within the same office visit. In practice, the process depends on the specific kit and device used, and occasional separation failures can require a repeat blood draw, a rare but real procedural hiccup patients should know about.

Regulatory clearance for PRP preparation devices is narrower than many patients assume. Most FDA-cleared systems are Class II devices indicated for preparing PRP to mix with bone graft material, not for approval of PRP as an injectable drug for tendon healing. That distinction matters when a clinic markets a specific kit as “FDA approved” for shoulder injections. It affects protocol transparency more than it affects safety, but it’s worth asking your provider about directly.

How strong is the research behind PRP for rotator cuff injuries?

The research base has grown substantially since 2023, and the picture that emerges is one of real but bounded benefit. A 2026 systematic review and meta-analysis pooling ten randomized controlled trials with 591 patients found that PRP produced measurable improvements over corticosteroid injections for rotator cuff tendinopathy. At six months, patients receiving PRP showed a mean improvement of 10.8 points on the ASES shoulder score and 10.7 points on the Constant-Murley score compared with corticosteroid, along with a 0.8-point reduction in pain on the visual analog scale and fewer adverse events overall.

A broader systematic review spanning thirty-six studies and roughly 2,000 patients reinforces this pattern. It found that PRP often delivers significant short-term pain relief and early gains on ASES and Constant scores, though long-term functional outcomes are inconsistent across trials. The same review noted that pooled data from some arthroscopic repair trials show lower retear rates when PRP is used as a surgical adjunct, with results reaching statistical significance in several analyses.

That surgical adjunct finding deserves its own spotlight. A meta-analysis focused specifically on arthroscopic rotator cuff repair reported a pooled retear rate lower in the PRP group compared to the control group, a difference that reached statistical significance (p=0.002) according to the pooled analysis. That’s a meaningful gap for patients worried about repair failure, though the same body of evidence shows long-term functional scores between PRP and non-PRP groups converging in many trials, meaning fewer retears don’t always translate into a clear functional edge years later.

Several factors explain why the evidence doesn’t point in one clean direction:

Formulation differences between LR-PRP and LP-PRP studies get pooled together in some meta-analyses, muddying the signal.
Technique variation, including injection site, number of injections, and whether PRP was applied intraoperatively or postoperatively, changes outcomes.
Tear size and chronicity differ across study populations, so a trial enrolling mostly small partial tears isn’t directly comparable to one enrolling large full-thickness tears.

The practical takeaway is straightforward. PRP has solid support for tendinopathy and partial-tear patients looking for symptom relief, and a defensible role as a surgical adjunct in select repair cases. It is not a universal substitute for surgery in large full-thickness tears, and no current guideline treats it as a stand-alone cure.

PRP compared with corticosteroid and hyaluronic acid injections

Choosing between injectable options often comes down to how fast you need relief and how long you want it to last. Corticosteroid injections work quickly, often easing pain within days, which makes them appealing for acute flare-ups. But that speed comes with a tradeoff: several RCTs and meta-analyses show PRP producing more durable benefits by the six-month mark, with the 2026 systematic review noting significantly better ASES and Constant-Murley scores for PRP compared with corticosteroid at that time point. If you’ve already tried a steroid injection and the relief faded within a few weeks, that pattern is worth discussing with your provider.

Hyaluronic acid (HA) adds another layer to the decision. A 2025 network meta-analysis of subacromial injections covering twenty randomized trials and 1,479 participants found that HA alone produced the best short-term pain and function outcomes, while HA combined with PRP showed superior results on some medium- and long-term functional measures compared with placebo and other injectables. PRP alone, in that same analysis, showed mixed pain relief beyond the three-month mark, underscoring that no single injectable dominates across every timeframe.

A few practical distinctions round out the comparison:

Corticosteroids act fast but repeated use carries more systemic risk, including tissue weakening with frequent injections.
PRP generally shows a favorable adverse event profile, with the 2026 meta-analysis reporting fewer adverse events overall compared with corticosteroid.
HA and HA+PRP combinations appear to offer a middle path, blending early relief with longer functional gains in some trials.

The clinical implication is that the “best” injectable depends on your goals. Someone needing quick relief before a specific event might lean toward corticosteroid or HA, while someone managing chronic tendinopathy who has already tried steroids might get more mileage from PRP or a combination approach. Our comparison of PRP and corticosteroid timelines for a different joint follows a similar pattern worth reviewing if you’re weighing the tradeoffs.

PRP as a surgical adjunct during rotator cuff repair

When a tear is large enough to require arthroscopic repair, PRP is sometimes applied directly at the tendon-bone healing interface rather than injected as a stand-alone treatment. Surgeons may layer PRP into the repair site to support the biological environment during healing, distinct from a subacromial injection used for tendinopathy alone.

But the AAOS 2025 Clinical Practice Guideline takes a measured stance rather than a blanket endorsement. It emphasizes optimizing the biological environment during repair and acknowledges the potential for liquid PRP to reduce retear rates in some surgical contexts, while noting that evidence supporting routine PRP use for patient-reported outcomes remains limited. The same guideline update points to bioinductive implants and dermal allografts as having stronger support in certain scenarios, suggesting PRP is one option among several biologic augmentation strategies rather than the default choice.

Where does that leave patients considering surgery?

Multi-tendon tears and repairs considered higher risk for failure are where surgeons most often discuss PRP augmentation.
Small, isolated tears with a good vascular bed may not need biologic augmentation at all.
Heterogeneity across trials means your surgeon’s experience and the specific repair technique matter as much as the general research.

Pro Tip: If your surgeon recommends PRP augmentation during repair, ask specifically whether it’s for the tendon-bone interface or a separate injection, since the evidence and rationale differ for each.

Who should consider PRP: a decision checklist

Deciding whether PRP fits your situation comes down to a handful of concrete questions. Walking through them before your appointment makes for a more productive conversation with your provider.

Confirm your tear type. Tendinopathy and partial-thickness tears have the strongest evidence for PRP as a stand-alone treatment, while large full-thickness tears usually point toward surgical evaluation.
Review your treatment history. Patients who’ve completed a meaningful course of physical therapy and possibly a corticosteroid injection without lasting relief are often better candidates than those just starting conservative care.
Consider how long you’ve had symptoms. Chronic tendinopathy that hasn’t responded to months of rest and therapy behaves differently than an acute strain, and PRP’s evidence base leans toward the chronic, treatment-resistant group.
Screen for contraindications. Active infection, uncontrolled bleeding disorders, and certain active cancers are reasons to delay or avoid PRP, and your provider should review your full medical history before proceeding.
Ask about the specifics. Which formulation (LR-PRP or LP-PRP) will be used, how many injections are planned, what timeline to expect for improvement, and what the procedure costs out of pocket.

Pro Tip: Bring a written list of every prior treatment you’ve tried for your shoulder, including dates and how long relief lasted, since that history often shapes whether PRP or another option makes more sense.

What to expect: the visit, recovery, and cost

A typical PRP appointment starts with a focused exam and often a review of prior imaging to confirm the tear type and rule out contraindications. The procedure itself is quick: a blood draw, roughly fifteen minutes of centrifugation while the plasma separates, and then an ultrasound-guided or landmark-guided injection into the shoulder. Most patients are in and out within an hour, with mild soreness at the injection site for a day or two afterward.

Recovery follows a two-track timeline. Early pain relief can begin within the first few weeks, but the biologic tendon healing that PRP is meant to support takes longer. Clinicians typically look for measurable improvement in the 8 to 12 week window, with fuller functional gains continuing to build through 3 to 6 months. That’s a longer arc than many patients expect walking in, and it’s worth setting that expectation up front rather than judging the treatment too early. Our detailed breakdown of the tendon-healing timeline covers what that progression typically looks like week by week.

Risks are generally modest. Transient soreness and mild swelling at the injection site are the most common complaints, and infection risk is rare with proper sterile technique. One less-discussed issue is device-related: MAUDE adverse event reports include cases where a PRP kit failed to separate the blood components properly, which can require a repeat draw. It’s uncommon, but knowing it’s possible helps you understand why a clinic might occasionally need a second attempt mid-procedure.

Cost is one of the more variable parts of the equation. PRP is frequently considered a self-pay treatment since insurance coverage for orthobiologic injections is inconsistent, and prices differ by clinic, region, and how many injections your protocol calls for. Before scheduling, it’s worth calling your insurer to ask about coverage and any preauthorization requirements, since policies on regenerative treatments shift more often than policies on standard orthopedic care.

How Nowak Orthopedic Associates applies the evidence

We evaluate PRP candidates the way the research suggests: tear type, treatment history, and symptom chronicity guide the conversation before any injection is scheduled. A board-certified orthopedic surgeon oversees this process within a broader Regenerative Medicine Clinic that also offers various non-surgical therapies, giving patients more than one non-surgical avenue when appropriate.

Our approach pairs PRP with structured follow-up rather than treating the injection as a stand-alone fix.

Candidate screening starts with imaging review and a documented history of prior conservative treatment.
Formulation and protocol are discussed openly with patients before consent, consistent with the variability the research describes.
Guided rehabilitation follows the injection to support the biologic healing window rather than leaving recovery to chance.

If you’re weighing PRP against other options, a direct conversation with our team can help match the evidence to your specific shoulder. You can reach out through our contact page to start that discussion.

Where the evidence leads and what gets overstated

The strongest case for PRP isn’t as a cure for rotator cuff disease, it’s as a reasonable middle option for patients stuck between “keep doing physical therapy” and “schedule surgery.” That’s a narrower claim than a lot of marketing around regenerative medicine implies, and patients deserve that honesty. The retear-rate data from surgical trials is genuinely encouraging, but it gets stretched too often into a blanket promise that PRP will fix any shoulder problem, which the research doesn’t support.

What gets underrated, in our view, is protocol transparency. Two patients can receive “PRP” and get meaningfully different biologic products depending on the kit, the leukocyte content, and the technique, yet both walk away describing the same treatment. If you take one thing from this guide, let it be this: ask your provider exactly what formulation you’re getting and why, before you ask whether PRP works in general. The formulation question is where the real decision lives.

— Dr. Roger Nowak

Scheduling a shoulder evaluation with our team

If you’re dealing with persistent shoulder pain and want to know whether PRP, physical therapy, or surgical repair fits your situation best, an in-person evaluation is the most reliable next step. Our Shoulder Care team reviews your imaging, prior treatment history, and current symptoms to build a plan specific to your tear and your goals, whether that means PRP injections through our Regenerative Medicine Clinic, guided physical therapy, or surgical repair when conservative options have run their course.

Before your first visit, gather any prior imaging (MRI or ultrasound reports), a list of treatments you’ve already tried, and referral paperwork if your primary care provider sent you our way. To schedule a consultation, contact Nowak Orthopedic Associates and our team will help you find a time that works.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

Sources

FAQ

Can a PRP injection actually heal a torn rotator cuff?

PRP is most effective for tendinopathy and partial-thickness tears, where it can improve pain and function, rather than fully regenerating a large full-thickness tear on its own. For larger tears, PRP is more often used as a supportive addition during surgical repair, where it has been linked to lower retear rates in some trials.

How much does a PRP injection for a rotator cuff tear cost?

Cost varies by clinic, region, and how many injections your treatment plan includes, and PRP is frequently billed as a self-pay procedure since insurance coverage is inconsistent. Contact your provider’s office directly and check with your insurer about coverage and preauthorization before scheduling.

How long does it take to recover from a PRP injection in the shoulder?

Mild soreness typically resolves within a few days, but the biologic healing process takes longer, with measurable improvement often appearing in the 8 to 12 week window after injection. Fuller functional gains tend to continue building through 3 to 6 months as the tendon responds to treatment.

Is PRP worth it for shoulder pain?

For many patients with tendinopathy or partial tears who haven’t gotten lasting relief from physical therapy or corticosteroids, PRP offers a reasonable, evidence-supported option with a favorable safety profile. It is not guaranteed to work for every shoulder problem, so discussing your specific tear type and treatment history with a provider is the best way to judge fit.